echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Ministry of human resources and social security: 44 drug varieties included in the scope of national negotiations

    Ministry of human resources and social security: 44 drug varieties included in the scope of national negotiations

    • Last Update: 2017-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: cctv.com 2017-04-17 [Huicong pharmaceutical industry.com] according to voice of China's CCTV news, at the end of February this year, the Ministry of human resources and social security released the 2017 version of the national drug catalog, and proposed some drugs to be negotiated The reporter learned from the Ministry of human resources and social security yesterday that 44 varieties of drugs proposed for negotiation by this part of expert review were finally determined to be included in the negotiation scope of national basic medical insurance, work injury insurance and maternity insurance drugs catalogue in 2017 after communicating the negotiation intention with production enterprises These 44 kinds of drugs, including apatinib mesylate, solafeni mesylate, erlotinib hydrochloride and other drugs that cover the treatment of lung cancer, gastric cancer and other common late stage tumors All the time, these drugs have been plagued by "good effect, high price and no reimbursement" According to he wenjiong, a professor of Zhejiang University and vice president of China social security society, this means that the "negotiation and access mechanism for medical insurance drugs" that experts and the industry have called for for for many years has officially entered the exploration stage "It's difficult to have any miscellaneous diseases Serious patients need special drugs This kind of medicine often uses fewer people and is expensive If the medical insurance catalog is included, the foundation will have an impact If we can negotiate, we will have the opportunity to consult with the druggist, and the medicine that the patient wants may be taken in the future " Song Ruilin, executive director of China pharmaceutical innovation promotion association, said that "with limited money, buy the most appropriate medicine" The way of negotiation is not only to ensure patients' medication, but also to ensure the smooth operation of medical insurance fund "As the payer, when adjusting the medical insurance catalog, we should not only ensure that people have medicine available, but also see whether the medical insurance payment ability is enough and whether there is so much money The biggest improvement in the system this time is the opening of the negotiation mechanism "
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.